Breast Cancer
Copper Trial for Triple-Negative Breast Cancer Officially Opens to Patients
In this Q&A, Linda T. Vahdat, MD, explains how cancer cells are master manipulators in the body and a promising way to stop them that she is studying in a new clinical trial.
An Event for Breast Health Learning, Sharing and Fellowship
Join us October 17 for Strength in Numbers: Supporting Survivors – An evening of breast health education.
A New Trial for “Triple Negative”
A promising multi-site clinical trial that has just opened at lead site Dartmouth Cancer Center looks to bring an innovative treatment strategy to one of the most challenging forms of breast cancer.
The Gallery of Light: Andrea and Caroline’s Story of Art in Healing
The paths of two breast cancer journeys intersect at a shared experience and love of art. The result is an enduring friendship.
Clinical trial trend shows better adherence to breast cancer medication
Data from the first year of a large clinical trial shows fewer side effects and better adherence to breast cancer medication when started before surgery.
Breast Cancer Screening Saves Lives
Watch this brief video to hear Dartmouth Cancer Center providers talk about breast cancer screening and its value.
Breast cancer research at Dartmouth Cancer Center
October is breast cancer awareness month. Here are just a few of the many breast cancer research projects happening at Dartmouth Cancer Center today.
New Dartmouth Health breast surgeon offers cutting-edge cancer-tracing technology for first time in New Hampshire
Dartmouth Health patients in southern New Hampshire now have access to a fellowship-trained breast surgeon, affiliated with a National Cancer Institute-designated Comprehensive Cancer Center, in their area.
New treatment possibility for ER+ breast cancer is headed toward clinical trials
A new study finds that combining estrogen and PARP inhibitors shows promise in treating ER+ breast cancer.
A promising new strategy to treat metastatic breast cancer
Results of a recent clinical trial show that alternating estrogen and anti-estrogen therapies is effective in treating metastatic breast cancer